ISPC stock rose 7% in morning trade on January 13, 2022, after the company announced it was expanding its specimen lab in New York. iSpecimen
Read more
Breaking news on biotech stocks and catalysts which includes FDA announcements, license agreements, and clinical trial data releases.
ISPC stock rose 7% in morning trade on January 13, 2022, after the company announced it was expanding its specimen lab in New York. iSpecimen
Read moreVIAC stock rose on January 12, 2022, after NFLCommunications.com published an article claiming NFL game viewership hit record highs. 2021 NFL season averaged 17.1M viewers
Read moreADGI stock rose 25% in after-hours trading on January 12, 2022, after the company said its drug is effective against omicron. Adagio Therapeutics Summarizes ADG20
Read moreMOLN stock rose more than 18% on January 11, 2022, after the company reported its clinical trial met its primary endpoint. Molecular Partners and Novartis
Read moreBCRX stock rocketed 15% higher in early trading on January 10, 2022, after the company posted preliminary financial data. BioCryst Announces Preliminary Full Year 2021
Read more